Sputnik Light single-dose vaccine launch in India may get delayed

An expert panel of the Central Drugs Standard Control Organisation asks company to conduct Phase-3 immune-bridging clinical trials on Indian population. Dr Reddy#39;s spokesperson declines to say when the trial will start.